(3-((Pyridin-2-ylmethyl)carbamoyl)phenyl)boronic acid

Catalog No. :
ACUVIS770
CAS No. :
874288-16-1
Molecular Formula :
C13H13BN2O3
Molecular Weight :
256.07

IUPAC Name:(3-((pyridin-2-ylmethyl)carbamoyl)phenyl)boronic acid

(3-((Pyridin-2-ylmethyl)carbamoyl)phenyl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$136.00Login to see priceInquiryInquiry
1g95%$341.00Login to see priceInquiryInquiry
5g95%$1025.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3-((Pyridin-2-ylmethyl)carbamoyl)phenyl)boronic acid
IUPAC Name(3-((pyridin-2-ylmethyl)carbamoyl)phenyl)boronic acid
Molecular FormulaC13H13BN2O3
Molecular Weight256.07
SMILESO=C(NCC1=NC=CC=C1)C2=CC(B(O)O)=CC=C2
InChI KeyLKKPMWPXBZNCEU-UHFFFAOYSA-N
SynonymBoronic acid, B-[3-[[(2-pyridinylmethyl)amino]carbonyl]phenyl]-;(3-((Pyridin-2-ylmethyl)carbamoyl)phenyl)boronic acid;B-[3-[[(2-Pyridinylmethyl)amino]carbonyl]phenyl]boronic acid
CAS No.874288-16-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUVIS770 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOBUP726 route compound structure diagram
    ACOBUP72625487-66-5 In Stock
  4. Then
  5. ACUVIS770 route product structure diagram
    ACUVIS770874288-16-1
Inquiry

2. ACUVIS770 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPHJG406 route compound structure diagram
    ACPHJG406332154-58-2 In Stock
  4. Then
  5. ACUVIS770 route product structure diagram
    ACUVIS770874288-16-1
Inquiry

Comments (0)